| 3.8 -0.21 (-5.24%) | 12-08 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.05  |
1-year : | 8.76 |
| Resists | First : | 5.18 |
Second : | 7.5 |
| Pivot price | 4.23 |
|||
| Supports | First : | 1.42 |
Second : | 1.18 |
| MAs | MA(5) : | 4.35 |
MA(20) : | 3.74 |
| MA(100) : | 1.69 |
MA(250) : | 0.99 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.7 |
| %K %D | K(14,3) : | 28.7 |
D(3) : | 38.3 |
| RSI | RSI(14): 53.4 |
|||
| 52-week | High : | 7.5 | Low : | 0.3 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SHOT ] has closed above bottom band by 32.2%. Bollinger Bands are 147.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 21 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 4.15 - 4.17 | 4.17 - 4.19 |
| Low: | 3.59 - 3.61 | 3.61 - 3.63 |
| Close: | 3.76 - 3.79 | 3.79 - 3.83 |
Jupiter Wellness, Inc., a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Thu, 07 Dec 2023
Thinking about buying stock in Boeing, Newegg Commerce, MicroAlgo, Safety Shot, or Sprinklr? - PR Newswire
Thu, 07 Dec 2023
Safety Shot Appoints Beverage Industry Innovator Rich Pascucci to its Board of Directors - GlobeNewswire
Thu, 07 Dec 2023
Safety Shot Appoints Rich Pascucci to Its Board of Directors - Marketscreener.com
Mon, 04 Dec 2023
Safety Shot is Now Available on Leading E-Commerce Platform Amazon.Com Product Sells Out Within Hours After ... - GlobeNewswire
Tue, 28 Nov 2023
Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter Wellness - Yahoo Finance
Sat, 25 Nov 2023
Safety Shot Stock: Mixed Sentiment After A 1000% Rally (NASDAQ:SHOT) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers—Specialty & Generic
|
|
| Shares Out | 46 (M) |
| Shares Float | 28 (M) |
| Held by Insiders | 44.9 (%) |
| Held by Institutions | 18.7 (%) |
| Shares Short | 1,420 (K) |
| Shares Short P.Month | 1,610 (K) |
| EPS | -0.74 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.18 |
| Profit Margin | 0 % |
| Operating Margin | -851.8 % |
| Return on Assets (ttm) | -73.6 % |
| Return on Equity (ttm) | -235 % |
| Qtrly Rev. Growth | -69.1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.1 |
| EBITDA (p.s.) | -0.3 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | 3 (M) |
| PE Ratio | -5.21 |
| PEG Ratio | 0 |
| Price to Book value | 21.11 |
| Price to Sales | 35.43 |
| Price to Cash Flow | -25.89 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|